To induce EAE in Rag1−/− mice, naive CD4+ T cells (CD4+CD25-CD62LhiCD44lo) from WT and RORγtcreCxxc1fl/fl or dLckcreCxxc1fl/fl mice were sorted by the Mouse CD4 Naïve T cell Enrichment Kit (no. 8804-6824-74, Invitrogen) and intravenously transferred into Rag1−/− mice at 2 × 106 cells per mouse. Two days later, the recipient mice were subjected to EAE induction.

Female age-matched Rag1−/− mice (8 to 10 weeks old) were immunized with an emulsion containing the MOG peptide MOG35–55 (200 μg per mouse; MEVGWYRSPFSRVVHLYRNGK; Sangon) in an equal amount of complete Freund’s adjuvant (200 μl per mouse; no. 7027, Chondrex Inc.). Pertussis toxin (200 ng per mouse; no. 181, List Biological Laboratories) was administered intravenously 0 and 2 days after induction. Clinical evaluation was performed daily using a five-point scale: 0, no clinical signs; 1, limp tail; 2, paraparesis (weakness, incomplete paralysis of one or two hind limbs); 3, paraplegia (complete paralysis of two hind limbs); 4, hind limb and fore limb paralysis; and 5, moribund or death.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.